![](/img/cover-not-exists.png)
Phase I/II study of metastatic melanoma patients treated with nivolumab who had progressed after ipilimumab
Weber, J., Gibney, G., Kudchadkar, R. R., Yu, B., Cheng, P., Martinez, A. J., Kroeger, J., Richards, A., McCormick, L., Moberg, V., Cronin, H., Zhao, X., Schell, M., Chen, Y. A.Language:
english
Journal:
Cancer Immunology Research
DOI:
10.1158/2326-6066.CIR-15-0193
Date:
February, 2016
File:
PDF, 944 KB
english, 2016